175 related articles for article (PubMed ID: 1318717)
1. Platelet-derived growth factor in human malignancy.
Silver BJ
Biofactors; 1992 Apr; 3(4):217-27. PubMed ID: 1318717
[TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor: roles in normal and v-sis transformed cells.
Deuel TF; Kimura A; Maehama S; Tong BD
Cancer Surv; 1985; 4(4):633-53. PubMed ID: 2824043
[TBL] [Abstract][Full Text] [Related]
4. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
5. The sis gene and PDGF.
Williams LT
Cancer Surv; 1986; 5(2):233-41. PubMed ID: 3536086
[TBL] [Abstract][Full Text] [Related]
6. Platelet-derived growth factor in human glioma.
Westermark B; Heldin CH; Nistér M
Glia; 1995 Nov; 15(3):257-63. PubMed ID: 8586462
[TBL] [Abstract][Full Text] [Related]
7. A high-molecular-weight PDGF-like factor secreted by v-sis transformed cells leads to growth stimulation and transformation.
Klein R; Thiel HJ
Oncogene Res; 1988 May; 2(4):311-24. PubMed ID: 2840622
[TBL] [Abstract][Full Text] [Related]
8. PDGF-D is a potent transforming and angiogenic growth factor.
Li H; Fredriksson L; Li X; Eriksson U
Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
[TBL] [Abstract][Full Text] [Related]
9. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
10. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines.
Nistér M; Libermann TA; Betsholtz C; Pettersson M; Claesson-Welsh L; Heldin CH; Schlessinger J; Westermark B
Cancer Res; 1988 Jul; 48(14):3910-8. PubMed ID: 2454731
[TBL] [Abstract][Full Text] [Related]
11. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
Potapova O; Fakhrai H; Mercola D
Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
[TBL] [Abstract][Full Text] [Related]
12. Identification and purification of PDGF/sis-like proteins from nuclei of simian sarcoma virus-transformed fibroblasts.
Pierce GF; Shawver LK; Milner PG; Yeh HJ; Thomason A; Deuel TF
Oncogene Res; 1988 Feb; 2(3):235-44. PubMed ID: 2835737
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
[TBL] [Abstract][Full Text] [Related]
14. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein.
Riese DJ; DiMaio D
Oncogene; 1995 Apr; 10(7):1431-9. PubMed ID: 7731695
[TBL] [Abstract][Full Text] [Related]
15. Growth factors and cancer.
Goustin AS; Leof EB; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
[TBL] [Abstract][Full Text] [Related]
16. Growth factors and oncogenes in human malignant glioma.
Westermark B; Nister M; Heldin CH
Neurol Clin; 1985 Nov; 3(4):785-99. PubMed ID: 3001490
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
18. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
19. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms for the expression and activity of platelet-derived growth factor receptor.
Funa K; Uramoto H
Acta Biochim Pol; 2003; 50(3):647-58. PubMed ID: 14515146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
